Vietnam’s strong healthcare deal activity in the last 12 months is consistent with strong global healthcare M&A activity. Hospital acquisitions in Vietnam led healthcare M&A activity. In 2023, the most significant M&A transaction was the acquisition of Ho Chi Minh City-based FV Hospital by Singapore’s Thomson Medical Group for USD381.4 million. In addition, Raffles Medical Group, a listed Singapore-based healthcare provider, announced its acquisition of a majority stake in the American International Hospital in Ho Chi Minh City, Vietnam, and entry into a management service agreement to manage the 120-bed tertiary hospital.
US private equity firms have also acquired significant assets in Vietnam. Warburg Pincus announced its investment in Ho Chi Minh City-based Xuyen A Hospital, a major private general hospital group in southern Vietnam. KKR acquired a majority stake in Medical Saigon Group from Heliconia Capital, a Singapore based private equity fund. CVC Capital Partners acquired 60% of shares in Phuong Chau Group which operates a hospital chain in the Mekong Delta.
There is also activity in Vietnam’s pharmaceutical sector. Dongwha Pharma, a Korean pharmaceuticals company, acquired a 51% stake in Vietnam’s Trung Son Pharma. Furthermore, Poland’s Adamed Pharma acquired a 100% stake in Dat Vi Phu Pharmaceuticals JSC.
According to the British Chamber of Commerce in the Vietnam Healthcare Report, there are 1,400 hospitals nationwide of which 17% are privately owned. That is significantly low to service a population of about 100 million. Hospitals remain the primary healthcare provider in Vietnam. The per capita healthcare spending in 2017 was USD170 and is estimated to grow to USD400 in 2027. 90% of medical devices in Vietnam are imported. These statistics present a substantial opportunity for investment in the healthcare sector in Vietnam.
The digital healthcare sector in Vietnam has experienced significant growth, driven by a surge in organisations ranging from ICT services to medical equipment distributors and start-ups, all aimed at improving healthcare services through technological innovations. The Vietnamese market has seen many health-tech start-ups catering to various market segments, including telehealth (such as JioHealth, Med247, and eDoctor), medical insurance compensation support services (such as Insmart and South Asia Services), and online pharmacies (such as Buymed and POC Pharma).
There has also been significant interest in hospital investments in Vietnam from global investment funds. These funds have a longer-term investment horizon where they are working to build a platform of hospital and healthcare facilities. Warburg Pincus, KKR and CVC Capital Partners are recent examples of these strategies.
Recent regulatory developments:
Draft Amendments to the Law on Pharmacy (2016):
New foreign invested start-ups in the healthcare sector typically use a Singapore holding company to establish the Vietnam subsidiary to operate the healthcare business in Vietnam. Singapore has promoted itself as the hub for the Southeast Asia operations. That said, holding companies in Hong Kong, Cyprus, Delaware and Luxembourg also work as the direct parent company of the Vietnam subsidiary.
The incorporation process for a wholly Vietnamese owned company is an easy process with little regulatory hurdles and requires five to ten days. However, incorporating a foreign invested enterprise will require the foreign investor obtaining an investment registration certificate (IRC) which approves the investment project of the foreign investor in Vietnam. The foreign investor must file a range of documents to the local department of planning and investment (DPI) showing corporate authority and financial capability to implement the project which will include a project business plan. Once the IRC is issued, an application is then made by the foreign investor to the DPI to obtain an enterprise registration certificate (ERC) which incorporates the foreign invested entity in Vietnam. Generally obtaining the IRC and ERC should take 6–8 weeks. However, given business in the healthcare sector for a foreign investor has regulatory hurdles, the DPI may consult with the Ministry of Health when assessing the application for IRC which may push the timing to 3–6 months.
100% foreign ownership is permitted in the healthcare sector. However, there are minimum investment capital requirements. A foreign invested hospital requires a minimum investment capital of USD20 million. A foreign invested polyclinic requires a minimum investment capital of USD2 million. A foreign invested speciality health facility requires a minimum investment capital of USD200,000.
A foreign-invested enterprise may use the following corporate forms:
A SMLLC and MMLLC do not issue shares and ownership in the entity is represented by the actual amount of capital contributed. A JSC can issue ordinary and other classes of shares and can potentially list on a Vietnam stock exchange. Entrepreneurs that want to provide an ESOP program for its employees and consultants would normally incorporate a JSC.
A start-up often raises seed investment through a variety of sources.
In early-stage financing the documentation is often less rigorous given the stage and size of the investment. The authors typically see the financing structured as a convertible loan agreement, share subscription agreement or a SAFE. The shareholder and governance arrangements are set out in the shareholders agreement and this will cover matters such as liquidation preference, next round financing and reserve matters.
There is limited access to capital from local venture capital and government-sponsored funds. This is because establishing a local fund structure requires regulatory approval. The authors see venture capital from local investors being provided through an offshore fund structure rather than onshore.
Foreign venture capital firms are active in the Vietnam market and global venture capital firms have made investments in Vietnam such as Sequoia Capital, Jungle Ventures, IDG Ventures, Y Combinator and SoftBank Vision Fund.
There are no standard venture capital documentation and standards in Vietnam. However, the Singapore Venture Capital and Private Capital Association together with the Singapore Academy of Law have developed Venture Capital Investment Model Agreements that include model term sheets, subscription agreement, convertible notes and shareholders agreement. These have been adopted in some transactions as a starting point for use in Vietnam.
Most start-ups in Vietnam will be established in the form of a joint stock company and, therefore, there is no need to migrate their corporate forms. However, the authors do see that in VC financing, the VC investor may request that the Vietnam entity and shareholders undertake a re-domiciliation to move the shareholding structure to a Singapore holding company with the Vietnam entity being a subsidiary of the Singapore holding company.
Investors would tend to run a sale process rather than undertake an IPO. This is because there has only been a small number of successful IPOs of start-up businesses with the key one being MobileWorld Group’s listing on the Ho Chi Minh City Stock Exchange in July 2014.
Although a listing on the local stock exchange is not normally a rigorous exercise and lawyers are not typically involved in the listing process, the local stock exchange is less liquid and Vietnam’s stock exchange is still classified as a frontier market. There are plans to elevate the stock market to an emerging market status in 2025 which would allow Vietnam to access greater global capital.
An IPO and listing of a Vietnamese company in an offshore securities exchange is challenging. There are Vietnam FDI and foreign ownership regulatory issues. Further, the strict corporate governance, accounting and reporting rules may mean that many Vietnamese companies may automatically not qualify. In addition, for a Vietnamese company to list offshore, that requires approval from the State Securities Commission of Vietnam and there is also a requirement for the Vietnam stock exchange and the offshore stock exchange to have entered into a co-operation agreement.
On that basis a trade sale is a more likely liquidity event for investors in a start-up. The start-up can engage an advisor for the sale process that can involve a competitive bidding process.
Vietnamese companies may find it more straightforward to list on the home country’s stock exchanges like HOSE or HNX due to familiarity with local regulations and reporting standards, and this is a more common practice for Vietnamese companies. In comparison, listing on a foreign exchange or dual listing can provide access to the greater capital market, as discussed, but can be more challenging.
For a Vietnamese company that is already listed on a Vietnam stock exchange to list its shares overseas, it must seek an approval from the State Securities Commission of Vietnam (SSC). Vietnamese companies typically require two to three years to prepare for an overseas listing. This is primarily due to differences between international and Vietnamese accounting standards, as well as the high standards demanded for corporate governance.
In the case of dual listing, Vietnamese companies are required to meet certain obligations pertaining to both Vietnam and the country where their shares are listed. These obligations include, among others, complying with Vietnamese foreign exchange controls and disclosure requirements stipulated by both Vietnamese stock exchange and foreign stock exchange, as well as Vietnamese laws on foreign ownership room for listed companies.
There has been no Vietnamese company that has achieved any dual listing or a listing of a Vietnamese company’s shares on an offshore stock exchange. VinFast is the first Vietnamese operated entity to have its offshore parent listed on a foreign stock exchange. However, while VinFast originated from Vietnam, it used a Singaporean entity to list on NASDAQ.
The authors have discussed the difficulty in listing a Vietnamese company in an offshore jurisdiction. If the company does succeed with an offshore listing, then there will be issues with any squeeze-out from a Vietnamese law perspective. This is because Vietnam’s securities law does not provide for any squeeze-out provisions for minority shareholders. Any acquisition of minority shares will need to be done by consent of the minority shareholder.
A competitive auction or bidding process is typically chosen.
The typical transaction structure is for a sale of a controlling interest with the founder or sponsor retaining 20% of the shareholding which would be subject to an earn-out in three to five years following completion.
The consideration is typically on a cash basis.
Founders are expected to stand behind customary representations and warranties though there are typical limitations of liability on the founders that relate to caps on liabilities (eg, 20–100% of purchase price depending on whether the warranty is fundamental or relates to tax or a general warranty), warranty claim period, double counting or double recovery, consequential loss and other customary limitations.
VC investors, unless they have a reasonable degree of management oversight, do not typically stand behind company warranties other than warranties relating to their ownership of the shares and warranties relating to power and authority and solvency of the VC investors.
A deposit or escrow arrangement are normally negotiated and agreed in healthcare transactions where the regulatory approval process and timeframe to satisfy the conditions precedent would be a lengthy one. The authors would typically see a deposit of 10–15% being paid after the signing of the transaction documents. A retention sum would normally be negotiated if there is a high likelihood that the completion and closing balance sheets would result in an adjustment to the purchase price in favour of the purchaser or if there is a concern about the future tax liability of the company following completion. The retention sum is typically around 5–10% of the purchase price.
Representation and Warranty Insurance are not commonly used in transactions, though the authors have seen an increasing number of PE firms using this insurance product for Vietnam M&A transactions.
Spin-offs or “company separation”, the better Vietnamese terminology, are not customary in Vietnam. This is because new healthcare licences and land title will need to be issued to the new entity following the spin-off which will be a lengthy process in Vietnam of 1–2 years. However, as a majority foreign owned company is not able to distribute pharmaceuticals on a retail/wholesale basis, the drug dispensing arm of a hospital or healthcare facility is normally carved out and restructured.
A company separation is a form of company reorganisation and generally does not give rise to any capital gains tax.
A spin-off immediately followed by a business combination is possible in Vietnam.
The business combination would require a range of regulatory approvals. The local DPI will need to approve the business combination. The Ministry of Health will generally need to provide an opinion on the business combination. Further, the licence of any additional healthcare facilities will need to be obtained from the local department of health. Depending on the size of the transaction an economic concentration notification may need to be filed with the Vietnam Competition Commission (VCC).
The timing for a spin-off is typically around two to three months. No tax ruling is required to be obtained.
There are no restrictions on acquiring shares before making a public tender offer in Vietnam. Investors may buy minority stakes as a “testing the waters” step.
Acquiring 5% or more of a company’s voting shares triggers disclosure obligations. The investor must report to the target company, SSC, and stock exchange within five business days. Similar reporting applies when selling shares that reduces ownership below 5% or by more than 1% (combined with affiliates).
While Vietnamese regulations do not explicitly require stating the acquisition’s purpose or future plans, the tender offer application to the SSC must include details such as funding source, acquisition rationale, and post-acquisition business plans. This indirectly addresses the purpose and plans.
Vietnam has no “put up or shut up” rule. The buyer does not need to make a formal offer or declare future intentions within a specific timeframe.
Vietnam has a mandatory offer threshold for public company acquisitions. An investor and their affiliated entities must make a public tender offer if their combined ownership reaches certain thresholds of the target company’s voting shares:
of the total voting shares.
The mandatory tender offer may be exempted if the acquisition is approved by the General Meeting of Shareholders of the target company.
In Vietnam, acquisitions of public companies are typically in form of share acquisition.
Asset acquisition is not common due to limitations. Certain assets, like land-use rights, might not be freely transferable or require specific approvals. Foreign investors may need to establish a new Vietnamese company to acquire the target’s assets.
Mergers are not as frequently used for public company acquisitions in Vietnam compared to share acquisitions, because:
So, while mergers are technically possible, the relative ease and efficiency of share acquisitions generally make them the preferred option for public company takeovers in Vietnam.
Public company acquisitions in Vietnam’s healthcare industry can be financed with either cash or shares. Cash remains the preferred method due to its simplicity and clarity for sellers. Stock-for-stock deals are less frequent, especially considering potential stock price volatility.
Vietnam implements a minimum price requirement specifically for cash tender offers. The offer price must not be lower than:
The investor cannot decrease the offer price during the tender offer period. However, increasing the offer price is allowed. Any price increase must be:
Contingent value rights (CVRs) are not yet a common tool in Vietnamese M&A. However, alternative mechanisms like earn-outs may be considered to bridge valuation gaps, especially in deals with high growth potential or significant regulatory uncertainties.
While takeover offers in Vietnam tend to be less conditional compared to some other jurisdictions, there are specific requirements that a tender offer must satisfy:
Beyond the specific conditions, the overall emphasis in Vietnam’s takeover offer process is on:
The Vietnamese takeover process emphasises transparency and shareholder decision-making, with less focus on pre-offer agreements and extensive representations and warranties from the target company.
Transaction Agreements in Vietnamese Takeovers
Unlike some other jurisdictions, Vietnam’s takeover framework does not typically involve formal transaction agreements between the bidder and target company before a public tender offer.
The primary legal document governing the acquisition is the tender offer document itself. This document outlines the offer terms, conditions, and procedures for shareholder participation.
Target Company Involvement
While a formal agreement is not customary, the target company might be of assistance in the following aspects during the tender process:
Board Recommendation
The target company’s board typically issues a recommendation to shareholders regarding the offer. However, this recommendation is not a formal agreement binding the company.
Representations and Warranties
Public companies in Vietnam are less likely to provide extensive representations and warranties compared to some other legal systems.
The board of directors of the target company must act in the best interests of the company and its shareholders. Providing extensive warranties could potentially conflict with this fiduciary duty.
The tender offer can include a minimum threshold of shares the investor seeks to acquire. This threshold is determined by the investor’s specific objectives, such as:
Vietnam’s Law on Securities does not include a “squeeze-out” provision forcing remaining shareholders to sell after a tender offer. However, there’s a mandatory buyback requirement if the investor successfully acquires more than 80% of the target company’s shares through the tender offer. In this scenario, the investor must offer to purchase any remaining shares from willing sellers at the same price terms as the original tender offer. This allows remaining shareholders a chance to exit but does not compel them to sell.
To launch a public tender offer in Vietnam, investors must prove they have sufficient funds. This is achieved by securing one of the following:
The investor must submit this financial evidence (payment guarantee or escrow certificate) to the SSC before the SSC confirms receipt of a complete tender offer dossier.
In Vietnam, the legal framework for public tender offers is still developing, and deal protection measures commonly used in other jurisdictions are not as prevalent.
Limited deal protection measures – target companies in Vietnam have limited options compared to some other countries. Break-up fees, matching rights, and force-the-vote provisions in mergers are not typically used.
Non-solicitation provisions – there is some possibility of using non-solicitation provisions in confidentiality agreements during the initial stages of exploring a potential deal. These provisions might restrict the target company from soliciting or negotiating with other potential bidders for a set period. However, the enforceability of such provisions in court can be uncertain.
While failing to acquire 100% ownership of a target company limits control, Vietnamese law still offers some rights to significant minority shareholders (holding 10% or more of voting shares, or a lower threshold specified in the company’s charter):
Board representation – these shareholders have the right to nominate individuals for the Board of Directors and Inspection Committee.
Voting rights – shareholder resolutions at general meetings can be passed with specific majority votes depending on the matter at hand:
Negotiating irrevocable commitments is uncommon in Vietnam, but not entirely absent. The enforceability of such agreements might be uncertain. In particular:
Limited use – Vietnamese regulations do not explicitly require or prohibit these commitments. However, they are not widely used due to a few factors:
Nature of undertakings (if used) – if such commitments are used, they would likely be structured as civil agreements between the bidder and the principal shareholders. These agreements might include:
“Out” Clauses – given the potential for competing bids, it is likely that any irrevocable commitment would include an “out” clause allowing the shareholder to exit the agreement if a superior offer emerges.
Launching a public tender offer in Vietnam involves a multi-step process with specific deadlines for both the investor and the target company:
Minimum and maximum duration – public tender offers in Vietnam must last for a minimum of 30 trading days and cannot exceed 60 trading days.
Extensions – generally, extensions are not granted unless the investor is already obligated to continue the offer due to exceeding a specific ownership threshold. See below.
Mandatory extension at 80% ownership – if the investor acquires 80% or more of the target company’s voting shares during the initial tender period, they are required by law to extend the offer and continue purchasing any remaining shares from willing sellers at the original offer price for an additional 30 days.
Antitrust approval – if the tender offer raises potential competition concerns, the investor needs clearance from VCC before submitting the application to the SSC. Obtaining competition clearance can take up to several months, potentially delaying the overall tender offer process.
Each sector of healthcare in Vietnam has distinct regulations. Understanding these is crucial for successful entry into the market. Among those sectors, attractive ones for foreign investors include: (i) healthcare services (hospitals, clinics and diagnostics); (ii) medical equipment; and (iii) pharmaceuticals.
Regulatory Landscape
The Ministry of Health (MOH) sets national healthcare policies and oversees technical guidelines. Local authorities manage health activities within their provinces. Key regulatory bodies include:
Regulations by Sector
1. Healthcare Services:
2. Medical equipment:
3. Pharmaceuticals:
The SSC is the primary regulator for mergers and acquisitions (M&A) involving listed companies in Vietnam. Operating under the Ministry of Finance (MOF), the SSC plays a crucial role in:
Vietnam’s healthcare industry welcomes foreign investment, governed by national investment laws and international treaties like WTO agreements and Free Trade Agreements (FTAs) with various partners. The specific conditions for foreign investors depend on the treaty they rely on.
Open Sectors
Healthcare and medical equipment – foreign investors generally face no limitations in establishing wholly foreign-owned companies, joint ventures, or business co-operation contracts for hospitals, medical and dental services, and medical equipment businesses.
Restricted Sector
Pharmaceuticals – foreign investors are currently prohibited from distributing pharmaceuticals in Vietnam. However, they can invest in pharmaceutical manufacturing and other aspects of the industry.
Navigating Investment Treaties
A country can belong to multiple international agreements with similar coverage. Therefore, foreign investors should choose the FTA that offers the most favourable conditions for their specific investment in Vietnam.
Capital Requirements and Treaty Benefits
Vietnam’s WTO commitments set minimum investment capital requirements for foreign hospitals, clinics, and specialty establishments. See 2.1 Establishing a New Company.
However, some FTAs, like the EU–Vietnam Free Trade Agreement (EVFTA), eliminate these capital requirements for member states, providing them with a competitive advantage.
Licences and Procedures
See 2.1 Establishing a New Company.
National Security Reviews
No Dedicated Process – Vietnam does not have a formal, centralised national security review process for all mergers and acquisitions. However, national defence and security considerations are still relevant in specific circumstances, particularly when:
Investor Restrictions Based on Nationality
Vietnam promotes foreign investment and generally does not have blanket restrictions based solely on investor nationality.
Foreign investors can leverage Free Trade Agreements (FTAs) with Vietnam for potentially more favourable conditions compared to WTO terms.
Export Control Regulations
Vietnam has export control regulations, which aim to control the export of goods, technologies, and services that could have potential military or security applications.
The Ministry of Industry and Trade (MOIT) is the primary authority responsible for export controls. Exporters are responsible for classifying their goods and obtaining any necessary licences before export.
The specific list of controlled goods is subject to change but can include items like weapons, ammunition, encryption software, and certain chemicals.
Vietnam’s Merger Control Process
Vietnam’s MOIT oversees merger control through VCC. A filing with the VCC is mandatory if a transaction involves a significant concentration of economic power in Vietnam, regardless of whether it is domestic or cross-border.
Economic concentration may be in form of (i) mergers; (ii) consolidations; (iii) acquisitions of shares or assets; and (iv) joint ventures.
When Is a Filing Required?
Filing is triggered if the transaction meets one of the following thresholds, with different thresholds applying to banking, insurance, and securities sectors:
Filing Process
The VCC conducts a two-step assessment:
Employee Rights and Liabilities
Acquirers in Vietnamese M&A transactions should be aware of key labour law regulations concerning:
Work Councils and Consultation
Vietnam does not mandate works councils. However, existing trade unions in the target company can play a role in employee representation and consultation during M&A, though their influence is limited.
Consulting with employee representatives or the trade union during the M&A process, especially if it involves workforce changes, is recommended for transparency and mitigating potential disputes.
Trade union opinions are not legally binding on the board of directors, who have ultimate decision-making authority.
Employee Transfer
The approach to employee transfers depends on the M&A transaction structure.
Asset transfer transactions
Employee transfers do not automatically occur with the asset transfer. Specific procedures will apply:
This approach aims for a smoother transition and clearer expectations.
Share transfer transactions – employees generally continue their employment with the target company unchanged.
Vietnam does have currency control regulations, but they generally do not require central bank approval for the entire M&A transaction itself.
Currency Control Regulations
Vietnam maintains some restrictions on foreign exchange transactions. These are overseen by the State Bank of Vietnam (SBV).
Foreign investors involved in M&A deals need to ensure they comply with these regulations when dealing with foreign currency. This will include using authorised channels for foreign currency exchange (including using the right specialised bank account for the payment of purchase price).
Central Bank Approval (Limited Cases)
In most M&A transactions, central bank approval for the overall deal is not required. However, there might be specific situations where SBV approval is necessary, such as acquisition of a bank or financial institution: The SBV regulates the banking and financial sector, and acquiring such an entity might require their approval.
There have not been any major court decisions reported publicly in the past three years that specifically deal with healthcare M&A transactions in Vietnam. Legal developments in this area tend to be through legislative changes or policy pronouncements, rather than court rulings.
Vietnam Streamlines Foreign Investment in Healthcare M&A
The revised Law on Investment, effective January 2021, simplifies foreign investment in Vietnamese M&A transactions, particularly within the healthcare sector. Here is how.
Shift from conditional access
Previously, foreign investors faced specific conditions for entering conditionally open business lines in healthcare. These conditions were defined in a complex web of laws, decrees, and treaties.
Clearer path forward
The revised law introduces a streamlined approach. It establishes a definitive list of restricted sectors, while all others allow foreign investors on equal footing with domestic players. This transparency and consistency make the investment process more efficient and predictable.
Healthcare sector benefits
Emerging fields like digital healthcare and telehealth, previously not explicitly open to foreign investment, can now potentially attract international capital. This is also a trend reiterated in the new Law on Medical Examination and Treatment 2023. This paves the way for:
Overall, the revised Law on Investment offers a more welcoming environment for foreign investors in the Vietnamese healthcare M&A landscape, potentially accelerating innovation and growth in the sector.
Board’s Authority and Insider Trading
The board of directors of the target public company ultimately decides:
Balancing Transparency and Confidentiality
The board must balance transparency for bidders with the need to protect confidential information. This might involve:
Board Fiduciary Duty and Insider Trading Rules
Board members have a fiduciary duty to act in the best interests of the company and its shareholders. This includes:
Fairness and Transparency for Bidders
Public companies have a legal obligation to treat all bidders fairly and transparently throughout the M&A process. This includes:
Level of Healthcare Due Diligence
The board’s decision on the acceptable level of healthcare due diligence should consider:
The scope of due diligence might encompass:
Public Offer Requirements and Information Disclosure
When making a public offer to acquire a public company, Vietnamese regulations require:
Therefore, the board will generally provide the same information to all qualified bidders to comply with these regulations and ensure a fair bidding process.
Data Protection Regulations
Vietnam’s regulations on personal data protection (in Decree 13/2023 and the Law on Medication Examination and Treatment 2023) govern data privacy and applies to the due diligence process in healthcare M&A transactions. Those regulations protect personal data, including sensitive information like patient health data.
Challenges for Due Diligence
The data privacy regulations generally require consent from the data subject (patient) before disclosing their personal data. Obtaining individual patient consent for all data involved in due diligence can be impractical.
Alternative approaches for data sharing:
Cross-Border Data Transfer Considerations
If the acquirer is a foreign entity, transferring Vietnamese citizen data requires additional steps:
Current Gap for Non-Vietnamese Citizens’ Data
There are currently no specific requirements for cross-border transfers of personal data for non-Vietnamese citizens residing in Vietnam. However, this is an evolving area, and regulations might change in the future.
See 6.2 Mandatory Offer and 6.13 Securities Regulator’s or Stock Exchange Process.
With respect to a stock-for-stock public tender offer, the offering party must submit a prospectus to the SSC, which needs to detail two key aspects:
Listing requirement for foreign acquirers – for foreign offering parties involved in a stock-for-stock public tender offer with a Vietnamese target company, an additional step is required. Upon completion of the offer, the foreign acquirer’s shares must be listed or registered for trading on a Vietnamese securities trading system.
The requirement for including financial statements in a public tender offer application depends on the type of offer:
Cash-Based Public Tender Offer
While not always mandatory, the SSC might request the foreign offering party’s financial statements during their review of the tender offer application. This helps them assess the financial capacity of the acquirer to complete the cash purchase.
Stock-for-Stock Public Tender Offer
Since stock-for-stock tender offer are considered public offers in Vietnam, the foreign offering party must register the offer and provide financial statements.
Financial statement requirements:
While the SSC does not require submitting the entire transaction agreement for a public tender offer, the application itself needs to disclose specific key terms and conditions, including:
By disclosing these essential details in the tender offer application, the SSC and target company shareholders have a clear understanding of the offer’s terms.
The Law on Enterprises outlines the core fiduciary duties of directors in Vietnam. These duties emphasise acting in the best interests of the company and its shareholders. In a business combination, this may translate to directors making decisions that maximise shareholder value, ensure the long-term sustainability of the company, and comply with all applicable laws and regulations.
Directors have a duty to provide full and fair disclosure of all material information concerning the business combination to the company’s shareholders. This information should allow shareholders to make informed decisions regarding the proposed transaction.
Directors must avoid conflicts of interest. They should not engage in any personal activities that could potentially harm the company or its shareholders. This is particularly important during business combinations where directors might have personal incentives that could influence their decisions.
It is not as common in Vietnam for boards of directors to establish special or ad hoc committees for business combinations. However, their use may be useful in larger or complex transactions. Here’s a breakdown of the reasons for and against using special committees, as well as the role of conflicts of interest.
Reasons for Using Special Committees
Reasons Why Special Committees Might Not Be Used As Often
Once the board receives a tender offer application from the bidder(s), Vietnamese regulations require them to disclose this information to the company’s shareholders within ten days. This disclosure should be accompanied by a written assessment and recommendation from the board itself.
The board’s assessment and recommendation typically focus on two key aspects:
In situations where the tender offer is considered “friendly” (meaning it is supported by the board), the offering entity or individual will typically engage in direct negotiations with the board. This allows for a more collaborative process and can help ensure the terms of the offer are mutually beneficial.
In Vietnamese business combinations and takeovers, directors typically rely on several forms of independent outside advice to make informed decisions. Here is a breakdown of the most common types.
Legal counsel – engaging experienced M&A lawyers is crucial. They advise the board on legal aspects of the transaction, ensure compliance with regulations, and help navigate potential conflicts of interest.
Financial advisors – financial advisors provide expertise in valuing the company and the target company (if applicable). They can also assist with:
Tax advisors – tax advisors are essential for understanding the potential tax consequences of the transaction for both the company and its shareholders.
Unit 9.10, Level 9, Deutsches Haus
33 Le Duan Boulevard
Ben Nghe Ward
District 1
Ho Chi Minh City
Vietnam
+84 28 38 22 77 67
minh@asia-counsel.com www.asia-counsel.comThe Healthcare Market in Vietnam
Demand
Vietnam has a population of approximately 100 million people and is currently classified by the World Bank as a lower-middle-income country. Vietnam’s population growth rate has steadily fallen during the last 60 years, from 3.9% in 1960 to 1.14% in 2019 and 0.84% in 2023. This population growth rate is expected to continue to decline during the foreseeable future. The corollary of this decline in population growth rate is an ageing population.
Vietnam aims to be elevated to upper-middle-income country status by 2035 and to high-income country status by 2045. According to the Ministry of Labour, Invalids, and Social Affairs of Vietnam (the MOLISA), a middle class (defined on the basis of per-capita spending from USD11 to USD110 per day) is forming rapidly in the large cities of Vietnam and accounts for approximately 13% of the total population (with this percentage expected to increase to 26% by 2026). Vietnam has been ranked fifth in the list of nine Asian countries which are forecasted to have the largest number of people entering the middle class in 2024.
The number of foreign citizens living and working in Vietnam is also steadily increasing. At the end of 2023, the approximate number of foreign citizens living and working in Vietnam was 136,800 – a significant increase when compared with the estimated number of 101,550 at the end of 2021.
An ageing population, rapidly expanding middle class, and increasing numbers of foreign workers are all factors which exert strong and positive influence on the growth of demand for quality healthcare services in Vietnam.
In addition, many Vietnamese people’s overall levels of health awareness have increased significantly as a result of the COVID-19 pandemic and its aftermath. This factor, combined with overcrowding within the public hospital system in Vietnam, have resulted in higher demand for general medical and long-term care services in Vietnam.
Healthcare market and state expenditure
Vietnam’s healthcare system consists of both public and private healthcare providers, overseen from a regulatory perspective by the Ministry of Health (the MOH).
Public hospitals are classified into central, provincial, district, and community levels – by reference to the level within Vietnam’s governmental hierarchy with which they are associated. Public hospitals currently play fundamentally important roles in the provision of healthcare services to people in Vietnam. For example, many Vietnamese people will present themselves at a public hospital in order to procure first-instance care – as opposed to the situation in many more developed countries, where people will in most cases consult with a private general practitioner at the local clinic before considering attendance at a hospital.
In 2023, there were approximately 1,500 registered hospitals in Vietnam, of which approximately 76.6% are public hospitals and approximately 23.4% were private hospitals. The majority of these hospitals are located in major urban areas such as Ho Chi Minh City, Hanoi and Danang.
In relation to healthcare expenditure in Vietnam, total expenditure appears to be divided between public and private expenditure in almost equal proportions. At the end of 2022, private sector expenditure accounted for approximately 47% of total healthcare expenditure in Vietnam, although only approximately 6% of the total number of hospital beds in Vietnam are provided by private operators. The Vietnamese government has stated in its key national healthcare network plans an intention to increase the proportion of private hospital beds (as compared with public hospital beds) up to 15% by 2030 and up to 25% by 2050.
Increasing demand for healthcare services has also driven significant increases in Vietnam’s national healthcare spending. According to the British Chamber of Commerce in Vietnam, Vietnam’s public healthcare spending has increased steadily and significantly during recent years, for example, per-capita public expenditure on healthcare services has increased from USD149 per capita per year in 2017 to USD164.9 per capita per year in 2022 – representing approximately a 2.5% increase per year. Projections through to 2032 anticipate that public healthcare spending will likely continue to increase at approximately 2.3% per year.
Regulation
Investment in the healthcare sector in Vietnam is regulated by two main legislative categories, namely:
Investment laws
The laws which primarily regulate investment activities and the operation of enterprises in Vietnam are the Law on Investment (2020) and the Law on Enterprises (2020) – together with their various respective implementing legislation – among others.
Under these key investment and related laws, there is no foreign ownership cap or other market access barriers which apply to foreign investors, in relation to the development, ownership, or operation of hospitals, except for certain requirements for minimum investment capital in relation to investment projects in the hospital sector. Nor are there any foreign ownership restrictions or market access barriers which apply in relation to the development, ownership, or operation of healthcare clinics.
On the other hand, whilst there are no foreign ownership restrictions or other market access barriers in relation to the manufacture of pharmaceutical products in Vietnam, foreign ownership in the pharmaceutical distribution sector is completely prohibited. Thus, although wholly or partly foreign owned companies may manufacture pharmaceutical products in Vietnam and/or import finished pharmaceutical products and/or manufacturing ingredients into Vietnam, only companies which are wholly owned by domestic investors may engage in wholesale or retail distribution of pharmaceutical products in Vietnam.
The private healthcare sector is eligible for investment incentives under the Law on Investment (2020). Eligible investors have the potential to enjoy a range of investment incentives, including the application of a lower corporate income tax rate, exemption from or reduction of import duties on certain types of imported goods, and/or exemption from or reduction of land use fees.
Healthcare laws
The provision of healthcare services in Vietnam is primarily governed by the Law on Medical Examination and Treatment (2023) (the “Medical Law”) and its implementing legislation. The current Medical Law was adopted by the National Assembly of Vietnam in 2023. Decree No 96/2023/NĐ-CP dated 30 December 2023 has been issued under the Medical Law and provides general guidance as to its implementation. The MOH is, however, in the process of developing further implementing decrees and circulars, to guide the implementation of the Medical Law.
All private healthcare facilities in Vietnam are required to obtain an operational licence from the MOH or the relevant provincial or municipal Department of Health (the DOH), depending on the scale and scope of their operations. Medical practitioners must also obtain specific licences in order to be able lawfully to practise medicine in Vietnam.
In terms of pharmaceutical products, the Law on Pharmacy (2016) is the key regulating law, together with its implementing legislation. The MOH has been working on a draft amendment to the Law on Pharmacy (2016) to provide additional regulations in connection with the distribution of pharmaceutical products in Vietnam and the State’s management of the pharmaceutical distribution industry. These draft amendments are scheduled to be submitted for the approval of the National Assembly in November 2024.
Recent Regulatory Developments
The Medical Law
The Medical Law (which came into force on 1 January 2024) aims to ensure patients’ access to high-quality medical examination and treatment services in accordance with international practices. The Medical Law also encourages the socialisation of medical examination and treatment activities, diversification of types of medical services, and ensuring fairness between public and private medical examination and treatment facilities.
Significant changes (as compared with the relevant predecessor legislation) which came into force along with the Medical Law on 1 January 2024 include the following.
Significantly, the Medical Law sets out a number of high-level principles in connection with development of medical examination and treatment facilities in Vietnam, including, among others, investment in the form of public–private partnership (PPP). The MOH is expected to issue an official circular during 2024, in relation to PPP investment in the development of medical examination and treatment facilities.
Draft amendments to the Law on Pharmacy (2016)
The MOH has been working on draft amendments to the Law on Pharmacy (2016) (the “Draft LOP Amendments”) and has sought public opinion in relation to the Draft LOP Amendments. The Draft LOP Amendments encompass various key aspects of the pharmaceutical industry in Vietnam, including:
The Draft LOP Amendments extend to foreign-invested enterprises (FIEs) business engagement rights in relation to wholesaling, forwarding, and transportation of pharmaceutical and medicinal products and ingredients having been produced, processed, and/or transferred by them. This extension of business engagement rights aims to attract foreign investment in the pharmaceutical sector in Vietnam. FIEs will also be entitled to certain business incentives when engaging in pharmaceutical business activities in Vietnam and be permitted to advertise pharmaceutical products in accordance with the applicable laws of Vietnam relating to advertising.
The Draft LOP Amendments also include provisions relating to conditions for conducting pharmaceutical business activities in the form of e-commerce, including the specific rights and responsibilities applicable to sellers of pharmaceutical products. The Draft LOP Amendments also address new types of business models which are not covered by the Law on Pharmacy (2016), such as pharmacy chain businesses, despite the fact that business models of this kind are already commonplace in the Vietnam market.
Healthcare Investment Trends
Attracting private investment in healthcare infrastructure
The COVID-19 crisis exposed shortcomings in Vietnam’s grassroots healthcare system, with overcrowded hospitals struggling due to outdated infrastructure and obsolete medical equipment. Despite increased budget allocations to the health sector, funding remains insufficient to meet public demand. Acknowledging this situation, the Vietnamese government has been actively promoting private investment to strengthen healthcare infrastructure and services.
This governmental initiative is reflected in the recent enactment of the Medical Law, which outlines certain mechanisms to attract private investment in the healthcare sector. The Medical Law contemplates private investment being encouraged in the following areas:
To encourage participation, investors are offered incentives such as favourable land use fees, tax benefits (including in relation to corporate income tax and importation duties for medical equipment) and access to credit facilities. Further specific legislation in relation to PPP investment in the healthcare sector is expected to be issued before the end of 2024.
Establishment of pharmaceutical industrial parks
In Vietnam, industrial parks are generally concerned with the manufacture or production of industrial products and attract various types of investment and business incentives, including favourable tax treatment. As outlined in Decision No 376/QD-TTg dated 17 March 2021 of the Prime Minister, which approves a programme for development of the pharmaceutical industry and domestically produced pharmaceutical materials in Vietnam through to 2030 with a vision to 2045, plans have been formulated to allocate land for the establishment of pharmaceutical industrial parks. The aim of these special-purpose industrial parks would be to attract both domestic and foreign investors to manufacture patented pharmaceutical products, specialised medications, generic pharmaceutical products with advanced dosage forms, vaccines, and medical-biological products, to meet both domestic and export demands.
In alignment with this vision, the MOH has recently collaborated with the municipal and provincial authorities of Ho Chi Minh City and Thai Binh province to establish pharmaceutical industrial parks in these regions. Ho Chi Minh City has designated Le Minh Xuan 2 Industrial Park (located in Binh Chanh district) for the development of a specialised medical and pharmaceutical industrial park spanning 338 hectares. This park will serve as a hub for research, development, and innovation in the medical and pharmaceutical fields. It will provide facilities for the production and trade of specialised medical and pharmaceutical products, focusing on the high-tech segment. Additionally, it will serve as a trading centre for specialised medical and pharmaceutical products and related items. Completion of the infrastructure for the Le Minh Xuan 2 Industrial Park is anticipated by 2030.
M&A in relation to hospitals and medical facilities
2023 and 2024 to date have been challenging periods for M&A transactions in Vietnam, mirroring worldwide trends. Despite these and other jurisdiction-specific headwinds, M&A activity in the healthcare sector remains robust. Several notable M&A transactions were completed in 2023, including Thomson Medical Group’s acquisition of FV Hospital for USD381.4 million and CVC Capital’s purchase of Phuong Chau International Hospital for USD116 million. Additionally, Raffles Medical Group (RMG) initiated a comprehensive strategic partnership with American International Hospital (AIH) in Ho Chi Minh City, with RMG commencing administrative and operational management activities at AIH from October 2023 and focusing on developing specialised services. In mid-April 2024, Warburg Pincus attracted attention by announcing its investment in the Xuyen A hospital system although details of this transaction had not yet come to light as at the date of publication of this article.
From a legal perspective, Vietnam’s healthcare sector continues to welcome foreign investment, aligning with the country’s commitments under its accession commitments to the WTO. Foreign investors have various options available to them for participation in the healthcare sector in Vietnam, including establishing wholly foreign-owned hospitals or clinics, forming joint ventures with Vietnamese partners, or entering into business co-operation contracts with local partners. The minimum investment capital required varies, depending upon the nature of an investment project in the healthcare sector, for example, USD20 million for hospitals, USD2 million for general clinics (polyclinics), and USD200,000 for specialised treatment facilities. These investment opportunities reflect Vietnam’s commitment to fostering collaboration and innovation in healthcare delivery while facilitating international partnerships to enhance the sector’s development and accessibility.
Medtech start-ups
Resolution 20-NQ/TW dated 25 October 2017 of the Communist Party of Vietnam on innovation, development, and enhancing collective economic efficiency, provided that medtech development is a key priority in Vietnam. This resolution underscores the importance of leveraging technology across various healthcare domains, spanning hospital management, health insurance assessment, electronic medical records, and remote diagnosis, testing, examination, and treatment. The market is proving this viewpoint to be accurate.
According to Statista data, Vietnam’s digital health market is poised for substantial revenue growth, with projections indicating a rise to USD905.8 million by 2024. Furthermore, a steady annual growth rate of 7.71% (CAGR 2024–2028) is anticipated, leading to a projected market volume of USD1.219 billion by 2028. Key technology areas targeted for development in Vietnam include electronic health records, telemedicine, artificial intelligence for disease diagnosis, and smart wearable devices for health monitoring.
Some noteworthy investment deals in the medtech start-up space include Mekong Capital’s USD21 million investment in Gene Solutions as part of its Series B round and BuyMed’s receipt of USD33.5 million from UOB Venture Management and other investors. These investments underscore the growing confidence in Vietnam’s medtech sector and its potential for innovation and growth.
While Vietnam lacks a clear legal framework specifically tailored to regulate medtech business, start-ups in this sector can navigate lawful business models within existing regulatory frameworks related to health, information technology, and personal data protection. Importantly, the government offers numerous incentives to support startups in science and technology, including tax breaks, financial assistance, and credit support. Medtech start-ups are well-positioned to capitalise on these incentives.
Outlook
Jurisdiction-specific factors such as changing demographics, deterioration of existing resources, increasing sophistication of patients, increases in chronic diseases and conditions, and the rapid development and adoption of technology, are expected to continue to drive strong market demand and M&A activity in the healthcare sector in Vietnam for the foreseeable future.
Unit 9.10, Level 9, Deutsches Haus
33 Le Duan Boulevard
Ben Nghe Ward
District 1
Ho Chi Minh City
Vietnam
+84 28 38 22 77 67
minh@asia-counsel.com www.asia-counsel.com